Dr. Isaacson
Claim this profileNEA Baptist clinic
Affiliated Hospitals
NEA Baptist Clinic
More about Isaacson
Clinical Trial Related
3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Isaacson has experience with
- Obicetrapib
- Placebo
Breakdown of trials Isaacson has run
Atherosclerosis
Cardiovascular Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Isaacson specialize in?
Isaacson focuses on Atherosclerosis and Cardiovascular Disease. In particular, much of their work with Atherosclerosis has involved treating patients, or patients who are undergoing treatment.
Is Isaacson currently recruiting for clinical trials?
No, Isaacson is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Isaacson has studied deeply?
Yes, Isaacson has studied treatments such as Obicetrapib, Placebo.
What is the best way to schedule an appointment with Isaacson?
Apply for one of the trials that Isaacson is conducting.
What is the office address of Isaacson?
The office of Isaacson is located at: NEA Baptist clinic, Jonesboro, Arkansas 72405 United States. This is the address for their practice at the NEA Baptist clinic.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.